Melinta Therapeutics Inc. buy stratec
Start price
29.10.18
/
50%
€11.50
Target price
23.12.19
€31.57
Performance (%)
-88.70%
End price
23.12.19
€1.30
Summary
This prediction ended on 23.12.19 with a price of €1.30. Massive losses of -88.70% were the result for the BUY prediction by stratec. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Melinta Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% | 59.631% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% | 98.396% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% | 50.544% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% | 63.586% |
Comments by stratec for this prediction
In the thread Melinta Therapeutics Inc. diskutieren
stratec stimmt der Buy-Einschätzung von Quitte zu
stratec stimmt am 29.10.2018 der Buy-Einschätzung von Quitte mit dem Kursziel 7$ zu.
Überschrift: die kommt